Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$411,605
in 5 filings

Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-13 SOUTHWELL DAVID P Director Grant or award · Stock Option (Right to Buy) +47,745 47,745
2022-06-13 BOESS CARSTEN Director Grant or award · Stock Option (Right to Buy) +47,745 47,745
2022-05-19 RTW INVESTMENTS, LP 10% owner Other acquisition · Equity Swap (obligation to buy) +1 1,000,000
2022-04-18 Militello John Other acquisition +7,932 32,352
2022-04-18 Militello John Other acquisition · Restricted Stock Units +7,932 0
2022-04-18 Militello John Grant or award · Stock Option (Right to Buy) +28,910 28,910
2022-04-18 Militello John Grant or award · Restricted Stock Units +19,054 19,054
2022-04-01 Schwartz Jonathan David Sale −12,974 $15.86 $206K 121,555
2022-04-01 Schwartz Jonathan David Sale −32,026 $16.20 $519K 89,529
2022-03-31 Schwartz Jonathan David Sale −9,002 $15.90 $143K 170,527
2022-03-31 Schwartz Jonathan David Sale −35,998 $16.15 $581K 134,529
2022-03-30 Schwartz Jonathan David Sale −10,562 $15.94 $168K 213,967
2022-03-30 Schwartz Jonathan David Sale −34,438 $16.56 $570K 179,529
2022-03-30 Schwartz Jonathan David Sale −10,562 $15.94 $168K 213,967
2022-03-30 Schwartz Jonathan David Sale −34,438 $16.56 $570K 179,529
2022-03-10 Malik Fady Ibraham Director Grant or award · Stock Option (Right to Buy) +33,199 33,199
2022-03-10 Malik Fady Ibraham Director Grant or award · Stock Option (Right to Buy) +8,641 8,641
2022-02-14 Shah Gaurav CEO Other acquisition +23,940 670,074
2022-02-14 Shah Gaurav CEO Other disposition · Restricted Stock Units −23,940 0
2022-02-14 Patel Kinnari Other acquisition +11,970 313,794

Page 20 of 27 · 538 trades